Literature DB >> 12738038

Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells.

Po-Lin Kuo1, Chun-Ching Lin.   

Abstract

The effects of tetrandrine in the human hepatoblastoma G2 (Hep G2) cell line were investigated in this study. The results showed that tetrandrine not only inhibited Hep G2 growth but also induced apoptosis and blocked cell cycle progression in the G1 phase. ELISA assay demonstrated that tetrandrine significantly increased the expression of p53 and p21/WAF1 protein, which caused cell cycle arrest. An enhancement in Fas/APO-1 and its two form ligands, membrane-bound Fas ligand (mFasL) and soluble Fas ligand (sFasL), might be responsible for the apoptotic effect induced by tetrandrine. Taken together, p53 and Fas/FasL apoptotic system possibly participated in the antiproliferative activity of tetrandrine in Hep G2 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738038     DOI: 10.1016/s0024-3205(03)00266-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  Growth-Suppressive and Apoptosis-Inducing Effects of Tetrandrine in SW872 Human Malignant Liposarcoma Cells via Activation of Caspase-9, Down-Regulation of XIAP and STAT-3, and ER Stress.

Authors:  Mohammed Samsuzzaman; Byeong-Churl Jang
Journal:  Biomolecules       Date:  2022-06-17

2.  An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion.

Authors:  Huae Xu; Zhibo Hou; Hao Zhang; Hui Kong; Xiaolin Li; Hong Wang; Weiping Xie
Journal:  Int J Nanomedicine       Date:  2013-12-27

3.  Inhibition on Proteasome β1 Subunit Might Contribute to the Anti-Cancer Effects of Fangchinoline in Human Prostate Cancer Cells.

Authors:  Dong Li; Yu Lu; Peng Sun; Li-Xing Feng; Miao Liu; Li-Hong Hu; Wan-Ying Wu; Bao-Hong Jiang; Min Yang; Xiao-Bo Qu; De-An Guo; Xuan Liu
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

4.  Tetrandrine suppresses adhesion, migration and invasion of human colon cancer SW620 cells via inhibition of nuclear factor-κB, matrix metalloproteinase-2 and matrix metalloproteinase-9 signaling pathways.

Authors:  Ta-Kuo Juan; Kuo-Ching Liu; Chao-Lin Kuo; Mei-Due Yang; Yung-Lin Chu; Jiun-Long Yang; Ping-Ping Wu; Yi-Ping Huang; Kuang-Chi Lai; Jing-Gung Chung
Journal:  Oncol Lett       Date:  2018-03-16       Impact factor: 2.967

5.  Purification, Preliminary Structure and Antitumor Activity of Exopolysaccharide Produced by Streptococcus thermophilus CH9.

Authors:  Naxin Sun; Huiping Liu; Shaojuan Liu; Xinyuan Zhang; Pei Chen; Weihong Li; Xiangxin Xu; Wentan Tian
Journal:  Molecules       Date:  2018-11-06       Impact factor: 4.411

Review 6.  Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint.

Authors:  Md Rezaul Islam; Fahadul Islam; Mohamed H Nafady; Muniya Akter; Saikat Mitra; Rajib Das; Humaira Urmee; Sheikh Shohag; Aklima Akter; Kumarappan Chidambaram; Fahad A Alhumaydhi; Talha Bin Emran; Simona Cavalu
Journal:  Molecules       Date:  2022-03-27       Impact factor: 4.411

7.  Alkaloids isolated from natural herbs as the anticancer agents.

Authors:  Jin-Jian Lu; Jiao-Lin Bao; Xiu-Ping Chen; Min Huang; Yi-Tao Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-04       Impact factor: 2.629

8.  Tetrandrine Suppresses Cancer Angiogenesis and Metastasis in 4T1 Tumor Bearing Mice.

Authors:  Jian-Li Gao; Xing Ji; Tong-Chuan He; Qi Zhang; Kai He; Yan Zhao; Su-Hong Chen; Gui-Yuan Lv
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-25       Impact factor: 2.629

9.  Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine.

Authors:  Jon Holy; Genelle Lamont; Edward Perkins
Journal:  BMC Cell Biol       Date:  2006-03-02       Impact factor: 4.241

10.  Synergistic effects of tetrandrine combined with ionizing radiation on a murine colorectal carcinoma‑bearing mouse model.

Authors:  Wei-Chan Lin; Wei-Hsun Wang; Yi-Hsien Lin; Jyh-Der Leu; Shan-Yun Cheng; Yu-Jen Chen; Jeng-Jong Hwang
Journal:  Oncol Rep       Date:  2018-07-12       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.